IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Nirman Agri Genetics IPO is a book build IPO listing on NSE EMERGE exchange. The company is based in Nashik and caters to Chemical - Pesticides sector. First Overseas Capital is the merchant banker of Nirman Agri Genetics IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 17th January 2023.
Nirman Agri Genetics IPO posted revenues of Rs 30.93 crores and PAT of Rs 3.94 crores in FY23 on annualised basis.Financial results of Nirman Agri Genetics IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
Nirman Agri Genetics IPO PAT Margin is 12.75%, ROCE (Return on Capital Employed) is 1.17% as per latest financial. The below table shows Nirman Agri Genetics IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
The market Capitalisation of Nirman Agri Genetics IPO is Rs 59.01 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Nirman Agri Genetics IPO prospectus highlights an Return on Equity (ROE) of 15%, Return on Assets (ROA) of 12%, and an EBITDA Margin of 18%, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Nirman Agri Genetics IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Nirman Agri Genetics IPO is ₹59.01 Cr, based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Nirman Agri Genetics IPO has a Price-to-Earnings (PE) ratio of 14.93 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Nirman Agri Genetics IPO reported revenue of ₹30.93 Cr in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Nirman Agri Genetics IPO provide insights into sales growth, market demand, and business scalability.
Nirman Agri Genetics recorded an EBITDA of ₹ 5.35 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Nirman Agri Genetics Profit After Tax (PAT) is ₹3.94 Cr, reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 30.93 Cr.
EBITDA Margin:
17.29
%
Net Worth: ₹ 4.47 Cr.
Market Capitalisation:
₹ 59.01 Cr.
P/E:
14.93 times
P/BV: 2.38 times
EV/EBITDA: 11.26 times
Nirman Agri Genetics operates in Chemical - Pesticides and Production Of Hybrid Seeds. The Issue is listed on NSE EMERGE in Mar, 2023. Nirman Agri Genetics IPO size was 20.30 with Issue price of 99.00 .
Merchant Banker(s) of Nirman Agri Genetics IPO: First Overseas Capital Limited
Nirman Agri Genetics IPO subscription was 1.71 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Nirman Agri Genetics IPO listed at a listing price of 102.00 against the offer price of 99.00.
The current market price of Nirman Agri Genetics is 263.55.
Why Us?
